- Rosuvastatine +22009 | First Faculty of Medicine
- Rosuvastatin-induced rhabdomyolysis due to medication errors2020 | First Faculty of Medicine
- Rosuvastatin/ezetimibe fixed combination2018 | Third Faculty of Medicine
- Rosuvastatin in the treatment of dyslipidemia2008 | First Faculty of Medicine
- Rosuvastatin in the treatment of dyslipidemia2008 | Publication without faculty affiliation
- Rosuvastatin in year 20112011 | First Faculty of Medicine
- Fixed-dose combination of rosuvastatin and ezetimibe2020 | First Faculty of Medicine
- Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure2010 | First Faculty of Medicine
- Development and optimization of methods for analysis of atorvastatin, rosuvastatin and its metabolites using UHPLC-MS/MS and MEPS sample preparation2012 | Faculty of Pharmacy in Hradec Králové
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis2009 | First Faculty of Medicine
- Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder2006 | First Faculty of Medicine
- Results of a non-interventional real-world evaluation (EZRA): a fixed combination of rosuvastatin and ezetimibe in patients with primary hypercholesterolemia2022 | First Faculty of Medicine
- Rosuvastatin and cardio vascular events in patients undergoing hemodialysis2009 | Faculty of Medicine in Hradec Králové
- Fall 2010: rosuvastatin, niacin and the new internal medicine2010 | First Faculty of Medicine
- Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA study)2010 | First Faculty of Medicine
- An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial2010 | First Faculty of Medicine
- Rosuvastatin - možnost bezpečného a rychlého snížení cholesterolu2016 | First Faculty of Medicine
- Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide2009 | First Faculty of Medicine
- Plasma concentration of Amino-Terminal Pro-Brain natriuretic peptide in chronic heart failure: Prediction of cardiovascular events and interaction with the effects of rosuvastatin a report from CORONA2009 | First Faculty of Medicine
- Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder2006 | Faculty of Medicine in Hradec Králové
- Fixed-combination of rosuvastatin with ezetimibe in the treatment of secondary prevention patient2018 | First Faculty of Medicine
- Rosuvastatin and cardio vascular events in patients undergoing hemodialysis2009 | First Faculty of Medicine
- VATARO - the story continues. Ordering a pilot study results2015 | First Faculty of Medicine
- Zkušenosti s fixní kombinací rosuvastatinu s ezetimibem2020 | Faculty of Medicine in Pilsen
- Advances of the contemporary treatment of hypertension and hypercholesterolemia by a new fixed combination2022 | Faculty of Medicine in Pilsen
- Rosuvastatin ve fixní kombinaci s ezetimibem: nová fixní kombinace, nové benefity pro nemocné2018 | Third Faculty of Medicine
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) A Retrospective Analysis2009 | First Faculty of Medicine
- CORONA trial - Should statins be prescribed to patients with heart failure?2008 | First Faculty of Medicine